Question · asked by 1 review

Topical mydriatics vs intracameral mydriatics: AE: participant‐reported ocular discomfort—week 1

Population
patients undergoing cataract surgery
Intervention
Topical mydriatics
Comparison
intracameral mydriatics
Outcome
AE: participant‐reported ocular discomfort—week 1

It is very uncertain whether topical mydriatics changes AE: participant‐reported ocular discomfort—week 1 compared with intracameral mydriatics (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Topical mydriatics vs intracameral mydriatics
AE: participant‐reported ocular discomfort—week 1 · patients undergoing cataract surgery
It is very uncertain whether topical mydriatics changes AE: participant‐reported ocular discomfort—week 1 compared with intracameral mydriatics (very low certainty).
Pharmacologic interventions for mydriasis in cataract surgery (2021) · Cochrane Headline outcomes only
RR 10.57 [1.37, 81.34]1 study · 555 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Pharmacologic interventions for mydriasis in cataract surgery
2021 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.